首页> 外文期刊>Open Journal of Medical Microbiology >Antimicrobial Susceptibility Patterns of Staphylococcus aureus Strains Isolated at the Namibia Institute of Pathology from 2012 to 2014
【24h】

Antimicrobial Susceptibility Patterns of Staphylococcus aureus Strains Isolated at the Namibia Institute of Pathology from 2012 to 2014

机译:2012年至2014年在纳米比亚病理研究所分离的金黄色葡萄球菌菌株的抗菌药敏模式

获取原文
           

摘要

Staphylococcus aureus (S. aureus) is known to acquire resistance to new drugs and continues to defy at-tempts to control it. Infections caused by antibiotic resistant strains of S. aureus have reached epidemic proportions globally and the increasing rates of antimicrobial resistance are resulting in fewer treatment options. Methicillin resistant S. aureus (MRSA) has also emerged as a serious therapeutic problem worldwide. However, data on the antimicrobial susceptibility patterns of this bacterium over a period of time in Namibia are not available. A descriptive retrospective study was therefore conducted to investigate the antimicrobial susceptibility patterns of 600 Staphylococcus aureus strains isolated at the Namibia Institute of Pathology (NIP) from January 2012 to December 2014. The results showed that a high proportion of isolates were resistant to penicillin (92.4%) and cotrimoxazole (44.9%), while the antibiotics to which the isolates were least resistant included vancomycin (0%), fusidic acid (0.3%) and ciprofloxacin (4.4%). Methicillin resistance was observed in 13.5% of the staphylococcal isolates. Apart from clindamycin (P value = 0.039) and cotrimoxazole (P value = 0.030), the susceptibility patterns of the antibiotics did not differ significantly over the three years. Moreover, wound swabs and sputum were the clinical samples from which S. aureus was most commonly isolated at NIP. The results from this study suggest that continuous local surveillance on the resistance patterns of S. aureus should be performed on regular basis in Namibia, in order to have adequate information for the empirical treatment of S. aureus infections.
机译:已知金黄色葡萄球菌(S. aureus)对新药产生抗药性,并继续无视控制它的尝试。由金黄色葡萄球菌的抗生素抗性菌株引起的感染已在全球范围内达到流行病的程度,并且抗药性耐药率的增加导致治疗选择的减少。耐甲氧西林的金黄色葡萄球菌(MRSA)在世界范围内也已成为严重的治疗问题。但是,有关纳米比亚一段时间内这种细菌的药敏模式的数据尚无。因此,我们进行了描述性回顾性研究,以调查2012年1月至2014年12月在纳米比亚病理学研究所(NIP)分离的600株金黄色葡萄球菌菌株的抗菌药敏感性模式。结果显示,很大一部分菌株对青霉素有抗药性(92.4 (%)和考特莫唑(44.9%),而分离株耐药性最低的抗生素包括万古霉素(0%),夫西地酸(0.3%)和环丙沙星(4.4%)。在13.5%的葡萄球菌分离物中观察到了耐甲氧西林。除克林霉素(P值= 0.039)和科曲唑(P值= 0.030)外,三年中抗生素的药敏模式没有显着差异。此外,伤口拭子和痰是在NIP最常从中分离出金黄色葡萄球菌的临床样品。这项研究的结果表明,在纳米比亚,应定期对金黄色葡萄球菌的耐药性模式进行连续的局部监测,以便为金黄色葡萄球菌感染的经验治疗提供足够的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号